OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 34

Showing 26-50 of 34 citing articles:

Tripterygium glycoside ameliorates kidney injury in diabetic rats by regulating the PI3K/Akt signaling pathway
Dandan HOU, Sainan SHANG, Juan Lv, et al.
Food Science and Technology (2022) Vol. 42
Open Access | Times Cited: 3

Cardiovascular and Renal Diseases in Type 2 Diabetes
Mukesh Nandave
(2024), pp. 151-247
Closed Access

Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes
Amirhossein Niknejad, Yasamin Hosseini, Hedieh Sadat Shamsnia, et al.
Cell Biochemistry and Biophysics (2023) Vol. 81, Iss. 4, pp. 599-613
Closed Access | Times Cited: 1

Az SGLT-2-gátlók hatásai a kardiovaszkuláris betegségekre, a szívelégtelenségre és a vesebetegségre – a nagy klinikai vizsgálatok áttekintése
Ferenc Sztanek, László Tóth, Attila Pető
Diabetologia Hungarica (2023) Vol. 31, Iss. 4, pp. 251-261
Open Access | Times Cited: 1

Cardio-Renal Benefits of GLP-1 Receptor Agonists vs. SGLT-2 Inhibitors in Type 2 Diabetes: Are They Juxtaposed?
Awadhesh Kumar Singh, Viral N. Shah
Clinical Diabetology (2022) Vol. 11, Iss. 4, pp. 215-221
Open Access | Times Cited: 2

Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus
Yu. G. Gorb, S. A. Serik, О. В. Ткаченко, et al.
Ukraïnsʹkij žurnal medicini bìologìï ta sportu (2022) Vol. 7, Iss. 1, pp. 14-31
Open Access | Times Cited: 1

SGLT-2i para a prevenção de eventos cardiovasculares em portadores com Diabetes mellitus tipo 2
Wellington Felipe do Nascimento Barros, Fábio Henrique Portella Corrêa de Oliveira
Research Society and Development (2022) Vol. 11, Iss. 8, pp. e18211830528-e18211830528
Open Access

Previous Page - Page 2

Scroll to top